Seoul National University Hospital

🇰🇷South Korea

Country: 🇰🇷South Korea

Ownership: Private

Established: 2003-01-01

Employees: 501

Market Cap: -

Website: https://www.snubh.org

Clinical Trials

A Pilot Study of Activated T Cell Therapy for Refractory/Relapsed Neuroblastoma

Not Applicable

Completed

Conditions: Neuroblastoma

Interventions: Biological: Activated T lymphocyte

First Posted Date: 2013-03-01

Last Posted Date: 2019-04-09

Lead Sponsor: Seoul National University Hospital

Target Recruit Count: 6

Registration Number: NCT01802138

Locations: 🇰🇷
Seoul National University Hospital, Seoul, Chongno-gu, Korea, Republic of

Predictors of Proton Pump Inhibitor Response in Gastroesophageal Reflux Disease Patients

Completed

Conditions: Erosive Reflux Disease
Non-erosive Reflux Disease
Functional Heartburn

First Posted Date: 2013-02-25

Last Posted Date: 2013-02-25

Lead Sponsor: Seoul National University Bundang Hospital

Target Recruit Count: 197

Registration Number: NCT01797939

Locations: 🇰🇷
Seoul National University Bundang Hospital, Seongnam, Gyeonggi-do, Korea, Republic of

Methylene Blue in Severe Sepsis and Septic Shock

Phase 3

Conditions: Severe Sepsis
Septic Shock

Interventions: Drug: Intravenous methylene blue administration
Drug: Placebo

First Posted Date: 2013-02-25

Last Posted Date: 2015-11-18

Lead Sponsor: Seoul National University Hospital

Target Recruit Count: 354

Registration Number: NCT01797978

Locations: 🇰🇷
SMG - SNU Boramae Medical Center, Seoul, Korea, Republic of
🇰🇷
Seoul National University Hospital, Seoul, Korea, Republic of
🇰🇷
Seoul National University Bundang Hospital, Seongnam-si, Kyeongi-do, Korea, Republic of

A Phase II Study of Axitinib in Metastatic Non-clear Cell Renal Cell Carcinoma Patients Previously Treated With Temsirolimus

Phase 2

Completed

Conditions: Renal Cell Carcinoma
Nonclear Cell
Temsirolimus Resistance

Interventions: Drug: Axitinib

First Posted Date: 2013-02-25

Last Posted Date: 2020-12-08

Lead Sponsor: Seoul National University Hospital

Target Recruit Count: 41

Registration Number: NCT01798446

Locations: 🇰🇷
Seou National University Hospital, Seoul, Korea, Republic of

Beraprost Sodium and Arterial Stiffness in Patients With Type 2 Diabetic Nephropathy

Not Applicable

Conditions: Diabetic Nephropathy

Interventions: Drug: Beraprost sodium

First Posted Date: 2013-02-21

Last Posted Date: 2013-12-16

Lead Sponsor: Seoul National University Hospital

Target Recruit Count: 102

Registration Number: NCT01796418

Locations: 🇰🇷
Hallym University Sacred Heart Hospital, Anyang, Korea, Republic of
🇰🇷
Seoul National University Hospital, Seoul, Korea, Republic of
🇰🇷
Kangnam Sacred Heart Hospital, Seoul, Korea, Republic of

and more 2 locations

Ranibizumab for Macular Edema Secondary to Branch Retinal Vein Occlusion in Patients With Fair Vision

Phase 4

Terminated

Conditions: Branch Retinal Vein Occlusion
Macular Edema

Interventions: Device: Sham injection
Drug: Ranibizumab
Procedure: Rescue laser

First Posted Date: 2013-02-20

Last Posted Date: 2019-09-19

Lead Sponsor: Seoul National University Bundang Hospital

Target Recruit Count: 19

Registration Number: NCT01795209

Locations: 🇰🇷
Seoul National University Bundang Hospital, Seongnam, Gyunggi-do, Korea, Republic of
🇰🇷
Samsung Medical Center, Seoul, Korea, Republic of

Lactobacillus Preparation on the Incidence of Diarrhea

Phase 4

Conditions: Diarrhea
Death
Pneumonia

Interventions: Drug: Lactobacillus casei variety rhamnosus granules
Drug: Placebo

First Posted Date: 2013-02-15

Last Posted Date: 2013-02-15

Lead Sponsor: Seoul National University Hospital

Target Recruit Count: 124

Registration Number: NCT01792739

Locations: 🇰🇷
Seoul National University Bundang Hospital, Seongnam, Bundang-Gu, Korea, Republic of
🇰🇷
Myongji Hospital, Goyang, Deokyang-gu, Korea, Republic of
🇰🇷
SMG-SNU Boramae Medical Center, Seoul, Dongjak-gu, Korea, Republic of

Long-term Follow up Helicobacter Pylori Reinfection Rate After Second-Line Treatment: Bismuth-Containing Quadruple Therapy Versus Moxifloxacin-Based Triple Therapy

Phase 4

Completed

Conditions: Helicobacter Infections

Interventions: Drug: esomeprazole
Drug: moxifloxacin
Drug: tripotassium dicitrate bismuthate
Drug: amoxicillin
Drug: metronidazole
Drug: tetracycline

First Posted Date: 2013-02-15

Last Posted Date: 2013-02-15

Lead Sponsor: Seoul National University Bundang Hospital

Target Recruit Count: 648

Registration Number: NCT01792700

Locations: 🇰🇷
Seoul National University Bundang Hospital, Seongnam, Gyeonggi-do, Korea, Republic of

Concurrent Membrane Sweeping With Dinoprostone Versus Dinoprostone in Labor Induction of Nulliparas at Term With an Unfavorable Cervix

Not Applicable

Completed

Conditions: Nulliparous Women Who Scheduled for Labor Induction

Interventions: Procedure: Concurrent membrane sweeping with Dinoprostone
Drug: 10mg Dinoprostone vaginal insert

First Posted Date: 2013-02-15

Last Posted Date: 2020-03-04

Lead Sponsor: Seoul National University Hospital

Target Recruit Count: 192

Registration Number: NCT01792375

Locations: 🇰🇷
Department of Obstetrics and Gynecology Seoul National University Bundang Hospital, Seongnam-si, Gyeonggi-do, Korea, Republic of

Tacrolimus/Methotrexate Versus Cyclosporine/Methotrexate for Prophylaxis of Graft Versus Host Disease

Phase 2

Completed

Conditions: Graft vs Host Disease

Interventions: Drug: Tacrolimus
Drug: Cyclosporine
Drug: Methotrexate

First Posted Date: 2013-02-11

Last Posted Date: 2017-03-22

Lead Sponsor: Seoul National University Hospital

Target Recruit Count: 50

Registration Number: NCT01788501

Locations: 🇰🇷
Asan Medical Center, Seoul, Korea, Republic of
🇰🇷
Samsung Medical Center, Seoul, Korea, Republic of
🇰🇷
Seoul National University Hospital, Seoul, Korea, Republic of

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy